TRK inhibition in soft tissue sarcomas: A comprehensive review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRK inhibition in soft tissue sarcomas: A comprehensive review

Published:2020-02 Issue:1 Volume:47 Page:73-84
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Assi Tarek^ORCID,Rassy Elie,Nassereddine Hussein,Farhat Fadi,Karak Fadi El,Kattan Joseph,Ghosn Marwan

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference73 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Trends in survival for patients with metastatic soft-tissue sarcoma;Italiano;Cancer,2011

3. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up;Casali;Ann Oncol.,2018

4. A review of soft-tissue sarcomas: translation of biological advances into treatment measures;Hoang;Cancer Manage Res,2018

5. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial;Seddon;Lancet Oncol,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence ofNTRKrearrangement;Journal of Clinical Pathology;2023-11-29

2. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China;Pathology;2023-04

3. Gene expression-based prediction of pazopanib efficacy in sarcoma;European Journal of Cancer;2022-09

4. Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions;Frontiers in Oncology;2022-06-16

5. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3